Rights and permissions
About this article
Cite this article
Hib vaccination programme `highly cost-beneficial' in the US. Pharmacoecon. Outcomes News 386, 9 (2002). https://doi.org/10.1007/BF03279795
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03279795